Pay in 4 interest-free payments of $5.60 Learn more
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12
I'm very satisfied with the product having used several others from different manufacturers
Hyperhomocysteinemia, a risk factor for atherosclerosis in chronic uremic patients
CJC-1295 (with DAC) is a modified GHRH analogue with an extended half-life achieved via Drug Affinity Complex (DAC) technology that covalently binds to serum albumin
Rule of 5 Limits to a series of molecular properties of drugs (logP, molecular weight, hydrogen bond donors and acceptors), suggested by Lipinski to increase the likelihood of good oral absorption
Nature 409:307312
US$ 22.05
US$ 23.44
US$ 26.50
US$ 28.95
US$ 26.26
US$ 24.05
